Benign maculopapular rash following dengue vaccination with Butantan-DV: a case series

This publication has 12 references indexed in Scilit:

• Long-term efficacy and safety of the single-dose tetravalent Butantan dengue vaccine
  Nature Medicine, 2026
• Randomized, double-blind, placebo-controlled, phase 3 trial to demonstrate lot-to-lot consistency of 3 lots of the simplified formulation of Butantan-dengue vaccine
  Vaccine, 2025
• Dermatological manifestations during Dengue, Chikungunya, and Zika infections
  Current Opinion in Infectious Diseases, 2024
• Efficacy and safety of Butantan-DV in participants aged 2–59 years through an extended follow-up: results from a double-blind, randomised, placebo-controlled, phase 3, multicentre trial in Brazil
  The Lancet Infectious Diseases, 2024
• Cutaneous reactions following CoronaVac COVID‐19 vaccination: a case series of six healthcare workers from a single centre
  Journal of the European Academy of Dermatology and Venereology, 2021
• Exanthematic dengue fever mimicking rubella
  Anais Brasileiros de Dermatologia, 2021
• Going Viral 2019
  Dermatologic Clinics, 2019
• Vaccine-associated hypersensitivity
  Journal of Allergy and Clinical Immunology, 2018
• Cutaneous reactions to vaccinations
  Clinics in Dermatology, 2015
• Manifestações mucocutâneas da dengue
  Anais Brasileiros de Dermatologia, 2007